1. Home
  2. SSP vs GBIO Comparison

SSP vs GBIO Comparison

Compare SSP & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SSP
  • GBIO
  • Stock Information
  • Founded
  • SSP 1878
  • GBIO 2016
  • Country
  • SSP United States
  • GBIO United States
  • Employees
  • SSP N/A
  • GBIO 174
  • Industry
  • SSP Broadcasting
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • SSP Industrials
  • GBIO Health Care
  • Exchange
  • SSP Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • SSP 173.3M
  • GBIO 145.5M
  • IPO Year
  • SSP 1988
  • GBIO 2020
  • Fundamental
  • Price
  • SSP $1.78
  • GBIO $2.18
  • Analyst Decision
  • SSP Buy
  • GBIO Buy
  • Analyst Count
  • SSP 2
  • GBIO 4
  • Target Price
  • SSP $7.75
  • GBIO $7.50
  • AVG Volume (30 Days)
  • SSP 649.4K
  • GBIO 65.6K
  • Earning Date
  • SSP 11-01-2024
  • GBIO 08-07-2024
  • Dividend Yield
  • SSP N/A
  • GBIO N/A
  • EPS Growth
  • SSP N/A
  • GBIO N/A
  • EPS
  • SSP N/A
  • GBIO N/A
  • Revenue
  • SSP $2,317,391,000.00
  • GBIO $13,174,000.00
  • Revenue This Year
  • SSP $8.99
  • GBIO $99.36
  • Revenue Next Year
  • SSP N/A
  • GBIO N/A
  • P/E Ratio
  • SSP N/A
  • GBIO N/A
  • Revenue Growth
  • SSP N/A
  • GBIO 1397.05
  • 52 Week Low
  • SSP $1.77
  • GBIO $0.86
  • 52 Week High
  • SSP $9.35
  • GBIO $4.83
  • Technical
  • Relative Strength Index (RSI)
  • SSP 30.88
  • GBIO 38.71
  • Support Level
  • SSP $1.99
  • GBIO $2.26
  • Resistance Level
  • SSP $2.19
  • GBIO $2.49
  • Average True Range (ATR)
  • SSP 0.14
  • GBIO 0.23
  • MACD
  • SSP -0.00
  • GBIO -0.03
  • Stochastic Oscillator
  • SSP 1.75
  • GBIO 1.85

About SSP E.W. Scripps Company (The)

The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: